nodes	percent_of_prediction	percent_of_DWPC	metapath
Daunorubicin—Topoisomerase Inhibitors—Irinotecan—colon cancer	0.589	1	CiPCiCtD
Daunorubicin—ABCB1—colon cancer	0.0827	1	CbGaD
Daunorubicin—ABCC10—Vincristine—colon cancer	0.0386	0.173	CbGbCtD
Daunorubicin—ABCC10—Methotrexate—colon cancer	0.0234	0.105	CbGbCtD
Daunorubicin—ABCB11—Vincristine—colon cancer	0.021	0.0939	CbGbCtD
Daunorubicin—ABCC1—Irinotecan—colon cancer	0.017	0.0763	CbGbCtD
Daunorubicin—ABCC1—Vincristine—colon cancer	0.0149	0.0667	CbGbCtD
Daunorubicin—ABCC2—Irinotecan—colon cancer	0.0126	0.0565	CbGbCtD
Daunorubicin—ABCG2—Irinotecan—colon cancer	0.0114	0.051	CbGbCtD
Daunorubicin—ABCC2—Vincristine—colon cancer	0.011	0.0493	CbGbCtD
Daunorubicin—ABCG2—Fluorouracil—colon cancer	0.0109	0.049	CbGbCtD
Daunorubicin—ABCG2—Vincristine—colon cancer	0.00997	0.0446	CbGbCtD
Daunorubicin—ABCC1—Methotrexate—colon cancer	0.00902	0.0404	CbGbCtD
Daunorubicin—ABCC2—Methotrexate—colon cancer	0.00668	0.0299	CbGbCtD
Daunorubicin—CYP3A5—Irinotecan—colon cancer	0.00632	0.0283	CbGbCtD
Daunorubicin—ABCG2—Methotrexate—colon cancer	0.00604	0.027	CbGbCtD
Daunorubicin—CYP3A5—Vincristine—colon cancer	0.00552	0.0247	CbGbCtD
Daunorubicin—CYP1A2—Fluorouracil—colon cancer	0.00451	0.0202	CbGbCtD
Daunorubicin—ABCB1—Irinotecan—colon cancer	0.00411	0.0184	CbGbCtD
Daunorubicin—ABCB1—Vincristine—colon cancer	0.0036	0.0161	CbGbCtD
Daunorubicin—ABCB11—bile—colon cancer	0.00355	0.141	CbGeAlD
Daunorubicin—CYP3A4—Irinotecan—colon cancer	0.00246	0.011	CbGbCtD
Daunorubicin—ABCB1—Methotrexate—colon cancer	0.00218	0.00974	CbGbCtD
Daunorubicin—CYP3A4—Vincristine—colon cancer	0.00215	0.00964	CbGbCtD
Daunorubicin—ABCC2—bile—colon cancer	0.0018	0.0717	CbGeAlD
Daunorubicin—TOP2B—Topotecan—Irinotecan—colon cancer	0.0012	0.714	CbGdCrCtD
Daunorubicin—TOP2B—embryo—colon cancer	0.000632	0.0251	CbGeAlD
Daunorubicin—NR5A1—lymphoid tissue—colon cancer	0.000623	0.0248	CbGeAlD
Daunorubicin—ABCC6—renal system—colon cancer	0.000527	0.021	CbGeAlD
Daunorubicin—YWHAG—smooth muscle tissue—colon cancer	0.000515	0.0205	CbGeAlD
Daunorubicin—TOP2B—smooth muscle tissue—colon cancer	0.000497	0.0197	CbGeAlD
Daunorubicin—YWHAG—renal system—colon cancer	0.000496	0.0197	CbGeAlD
Daunorubicin—XDH—renal system—colon cancer	0.000484	0.0192	CbGeAlD
Daunorubicin—TOP2B—renal system—colon cancer	0.000478	0.019	CbGeAlD
Daunorubicin—YWHAG—lymphoid tissue—colon cancer	0.000412	0.0164	CbGeAlD
Daunorubicin—YWHAG—digestive system—colon cancer	0.000407	0.0162	CbGeAlD
Daunorubicin—TOP2B—lymphoid tissue—colon cancer	0.000397	0.0158	CbGeAlD
Daunorubicin—XDH—digestive system—colon cancer	0.000397	0.0158	CbGeAlD
Daunorubicin—TOP2B—digestive system—colon cancer	0.000392	0.0156	CbGeAlD
Daunorubicin—ABCB11—digestive system—colon cancer	0.000388	0.0154	CbGeAlD
Daunorubicin—SLC22A2—renal system—colon cancer	0.000379	0.0151	CbGeAlD
Daunorubicin—YWHAG—bone marrow—colon cancer	0.000375	0.0149	CbGeAlD
Daunorubicin—TOP2B—bone marrow—colon cancer	0.000361	0.0144	CbGeAlD
Daunorubicin—YWHAG—vagina—colon cancer	0.000359	0.0143	CbGeAlD
Daunorubicin—XDH—vagina—colon cancer	0.00035	0.0139	CbGeAlD
Daunorubicin—TOP2B—vagina—colon cancer	0.000346	0.0138	CbGeAlD
Daunorubicin—ABCC6—liver—colon cancer	0.000322	0.0128	CbGeAlD
Daunorubicin—SLC22A2—digestive system—colon cancer	0.000311	0.0124	CbGeAlD
Daunorubicin—YWHAG—liver—colon cancer	0.000303	0.0121	CbGeAlD
Daunorubicin—ABCC10—renal system—colon cancer	0.000299	0.0119	CbGeAlD
Daunorubicin—XDH—liver—colon cancer	0.000296	0.0118	CbGeAlD
Daunorubicin—TOP2B—liver—colon cancer	0.000292	0.0116	CbGeAlD
Daunorubicin—ABCB11—liver—colon cancer	0.000289	0.0115	CbGeAlD
Daunorubicin—POR—bone marrow—colon cancer	0.000285	0.0113	CbGeAlD
Daunorubicin—POR—vagina—colon cancer	0.000273	0.0109	CbGeAlD
Daunorubicin—TOP2A—bone marrow—colon cancer	0.000266	0.0106	CbGeAlD
Daunorubicin—TOP2A—vagina—colon cancer	0.000255	0.0101	CbGeAlD
Daunorubicin—ABCC10—lymphoid tissue—colon cancer	0.000249	0.00988	CbGeAlD
Daunorubicin—ABCC10—digestive system—colon cancer	0.000245	0.00976	CbGeAlD
Daunorubicin—CYP1B1—smooth muscle tissue—colon cancer	0.000244	0.00972	CbGeAlD
Daunorubicin—ABCC2—renal system—colon cancer	0.00024	0.00956	CbGeAlD
Daunorubicin—CYP1B1—renal system—colon cancer	0.000235	0.00936	CbGeAlD
Daunorubicin—YWHAG—lymph node—colon cancer	0.000232	0.00924	CbGeAlD
Daunorubicin—POR—liver—colon cancer	0.00023	0.00916	CbGeAlD
Daunorubicin—ABCC10—bone marrow—colon cancer	0.000226	0.009	CbGeAlD
Daunorubicin—TOP2B—lymph node—colon cancer	0.000224	0.00891	CbGeAlD
Daunorubicin—ABCC10—vagina—colon cancer	0.000217	0.00862	CbGeAlD
Daunorubicin—ABCC2—digestive system—colon cancer	0.000197	0.00784	CbGeAlD
Daunorubicin—CYP1B1—lymphoid tissue—colon cancer	0.000195	0.00777	CbGeAlD
Daunorubicin—TOP2A—Topotecan—Irinotecan—colon cancer	0.000194	0.115	CbGdCrCtD
Daunorubicin—CYP1B1—digestive system—colon cancer	0.000193	0.00768	CbGeAlD
Daunorubicin—ABCB1—blood vessel—colon cancer	0.000191	0.00761	CbGeAlD
Daunorubicin—ABCC10—liver—colon cancer	0.000183	0.00727	CbGeAlD
Daunorubicin—CYP1A1—epithelium—colon cancer	0.000179	0.00713	CbGeAlD
Daunorubicin—POR—lymph node—colon cancer	0.000177	0.00703	CbGeAlD
Daunorubicin—CYP1A2—renal system—colon cancer	0.000169	0.00671	CbGeAlD
Daunorubicin—CYP1A1—renal system—colon cancer	0.000166	0.00662	CbGeAlD
Daunorubicin—TOP2A—lymph node—colon cancer	0.000165	0.00655	CbGeAlD
Daunorubicin—CYP3A5—renal system—colon cancer	0.000163	0.00647	CbGeAlD
Daunorubicin—ABCC1—vagina—colon cancer	0.000153	0.0061	CbGeAlD
Daunorubicin—ABCC2—liver—colon cancer	0.000147	0.00584	CbGeAlD
Daunorubicin—CYP1B1—liver—colon cancer	0.000144	0.00572	CbGeAlD
Daunorubicin—ABCC10—lymph node—colon cancer	0.00014	0.00558	CbGeAlD
Daunorubicin—TOP2A—Vindesine—Vincristine—colon cancer	0.000139	0.0825	CbGdCrCtD
Daunorubicin—CYP1A2—digestive system—colon cancer	0.000138	0.0055	CbGeAlD
Daunorubicin—CYP1A1—digestive system—colon cancer	0.000136	0.00543	CbGeAlD
Daunorubicin—CYP3A5—digestive system—colon cancer	0.000133	0.00531	CbGeAlD
Daunorubicin—ABCG2—bone marrow—colon cancer	0.000132	0.00527	CbGeAlD
Daunorubicin—ABCC1—liver—colon cancer	0.000129	0.00514	CbGeAlD
Daunorubicin—ABCG2—vagina—colon cancer	0.000127	0.00505	CbGeAlD
Daunorubicin—CYP3A4—renal system—colon cancer	0.000122	0.00485	CbGeAlD
Daunorubicin—CYP1A1—vagina—colon cancer	0.00012	0.00479	CbGeAlD
Daunorubicin—CYP3A5—vagina—colon cancer	0.000118	0.00469	CbGeAlD
Daunorubicin—ABCB1—embryo—colon cancer	0.000114	0.00454	CbGeAlD
Daunorubicin—ABCC2—lymph node—colon cancer	0.000113	0.00448	CbGeAlD
Daunorubicin—Melaena—Methotrexate—colon cancer	0.000112	0.00212	CcSEcCtD
Daunorubicin—Gastrointestinal haemorrhage—Capecitabine—colon cancer	0.000111	0.00211	CcSEcCtD
Daunorubicin—Visual impairment—Irinotecan—colon cancer	0.000111	0.00211	CcSEcCtD
Daunorubicin—Rhinitis—Fluorouracil—colon cancer	0.000111	0.0021	CcSEcCtD
Daunorubicin—CYP1B1—lymph node—colon cancer	0.00011	0.00438	CbGeAlD
Daunorubicin—Cardiac disorder—Vincristine—colon cancer	0.00011	0.00208	CcSEcCtD
Daunorubicin—ABCG2—liver—colon cancer	0.000107	0.00426	CbGeAlD
Daunorubicin—Flushing—Irinotecan—colon cancer	0.000107	0.00203	CcSEcCtD
Daunorubicin—Cardiac disorder—Irinotecan—colon cancer	0.000107	0.00203	CcSEcCtD
Daunorubicin—Cardiac arrest—Capecitabine—colon cancer	0.000106	0.00201	CcSEcCtD
Daunorubicin—Mood swings—Capecitabine—colon cancer	0.000106	0.002	CcSEcCtD
Daunorubicin—Ataxia—Capecitabine—colon cancer	0.000105	0.00199	CcSEcCtD
Daunorubicin—Alopecia—Vincristine—colon cancer	0.000104	0.00198	CcSEcCtD
Daunorubicin—Dehydration—Capecitabine—colon cancer	0.000104	0.00197	CcSEcCtD
Daunorubicin—Chills—Irinotecan—colon cancer	0.000103	0.00196	CcSEcCtD
Daunorubicin—Urine output increased—Methotrexate—colon cancer	0.000103	0.00196	CcSEcCtD
Daunorubicin—CYP1A2—liver—colon cancer	0.000103	0.0041	CbGeAlD
Daunorubicin—Arrhythmia—Irinotecan—colon cancer	0.000103	0.00195	CcSEcCtD
Daunorubicin—Dry skin—Capecitabine—colon cancer	0.000102	0.00194	CcSEcCtD
Daunorubicin—Alopecia—Irinotecan—colon cancer	0.000102	0.00193	CcSEcCtD
Daunorubicin—CYP1A1—liver—colon cancer	0.000102	0.00404	CbGeAlD
Daunorubicin—CYP3A4—digestive system—colon cancer	0.0001	0.00398	CbGeAlD
Daunorubicin—Back pain—Vincristine—colon cancer	9.96e-05	0.00189	CcSEcCtD
Daunorubicin—CYP3A5—liver—colon cancer	9.94e-05	0.00395	CbGeAlD
Daunorubicin—ABCC1—lymph node—colon cancer	9.92e-05	0.00394	CbGeAlD
Daunorubicin—Gastritis—Capecitabine—colon cancer	9.86e-05	0.00187	CcSEcCtD
Daunorubicin—Arrhythmia—Fluorouracil—colon cancer	9.85e-05	0.00187	CcSEcCtD
Daunorubicin—Alopecia—Fluorouracil—colon cancer	9.75e-05	0.00185	CcSEcCtD
Daunorubicin—Lymphadenopathy—Methotrexate—colon cancer	9.72e-05	0.00184	CcSEcCtD
Daunorubicin—Back pain—Irinotecan—colon cancer	9.7e-05	0.00184	CcSEcCtD
Daunorubicin—Dysphagia—Capecitabine—colon cancer	9.63e-05	0.00183	CcSEcCtD
Daunorubicin—Erythema—Fluorouracil—colon cancer	9.6e-05	0.00182	CcSEcCtD
Daunorubicin—Thrombophlebitis—Methotrexate—colon cancer	9.58e-05	0.00182	CcSEcCtD
Daunorubicin—Anaemia—Vincristine—colon cancer	9.51e-05	0.00181	CcSEcCtD
Daunorubicin—Agitation—Vincristine—colon cancer	9.46e-05	0.00179	CcSEcCtD
Daunorubicin—Polyuria—Methotrexate—colon cancer	9.44e-05	0.00179	CcSEcCtD
Daunorubicin—Sweating increased—Capecitabine—colon cancer	9.38e-05	0.00178	CcSEcCtD
Daunorubicin—Angina pectoris—Capecitabine—colon cancer	9.38e-05	0.00178	CcSEcCtD
Daunorubicin—ABCB1—epithelium—colon cancer	9.32e-05	0.0037	CbGeAlD
Daunorubicin—Ill-defined disorder—Irinotecan—colon cancer	9.3e-05	0.00176	CcSEcCtD
Daunorubicin—Anaemia—Irinotecan—colon cancer	9.27e-05	0.00176	CcSEcCtD
Daunorubicin—Leukopenia—Vincristine—colon cancer	9.21e-05	0.00175	CcSEcCtD
Daunorubicin—Pancytopenia—Capecitabine—colon cancer	9.14e-05	0.00174	CcSEcCtD
Daunorubicin—Malaise—Irinotecan—colon cancer	9.04e-05	0.00172	CcSEcCtD
Daunorubicin—Dysuria—Capecitabine—colon cancer	9e-05	0.00171	CcSEcCtD
Daunorubicin—Neutropenia—Capecitabine—colon cancer	9e-05	0.00171	CcSEcCtD
Daunorubicin—Syncope—Irinotecan—colon cancer	8.99e-05	0.00171	CcSEcCtD
Daunorubicin—Leukopenia—Irinotecan—colon cancer	8.97e-05	0.0017	CcSEcCtD
Daunorubicin—Convulsion—Vincristine—colon cancer	8.92e-05	0.00169	CcSEcCtD
Daunorubicin—Hypertension—Vincristine—colon cancer	8.89e-05	0.00169	CcSEcCtD
Daunorubicin—Anaemia—Fluorouracil—colon cancer	8.87e-05	0.00168	CcSEcCtD
Daunorubicin—Loss of consciousness—Irinotecan—colon cancer	8.81e-05	0.00167	CcSEcCtD
Daunorubicin—Myalgia—Vincristine—colon cancer	8.76e-05	0.00166	CcSEcCtD
Daunorubicin—TOP2A—Vinorelbine—Vincristine—colon cancer	8.76e-05	0.0521	CbGdCrCtD
Daunorubicin—Cough—Irinotecan—colon cancer	8.75e-05	0.00166	CcSEcCtD
Daunorubicin—Hypertension—Irinotecan—colon cancer	8.65e-05	0.00164	CcSEcCtD
Daunorubicin—ABCB1—renal system—colon cancer	8.64e-05	0.00344	CbGeAlD
Daunorubicin—Leukopenia—Fluorouracil—colon cancer	8.59e-05	0.00163	CcSEcCtD
Daunorubicin—Anaphylactoid reaction—Methotrexate—colon cancer	8.57e-05	0.00163	CcSEcCtD
Daunorubicin—Depression—Capecitabine—colon cancer	8.56e-05	0.00162	CcSEcCtD
Daunorubicin—Acute coronary syndrome—Capecitabine—colon cancer	8.46e-05	0.00161	CcSEcCtD
Daunorubicin—Renal failure—Capecitabine—colon cancer	8.44e-05	0.0016	CcSEcCtD
Daunorubicin—Discomfort—Irinotecan—colon cancer	8.43e-05	0.0016	CcSEcCtD
Daunorubicin—Neuropathy peripheral—Capecitabine—colon cancer	8.42e-05	0.0016	CcSEcCtD
Daunorubicin—Myocardial infarction—Capecitabine—colon cancer	8.42e-05	0.0016	CcSEcCtD
Daunorubicin—Anaphylactic shock—Vincristine—colon cancer	8.4e-05	0.00159	CcSEcCtD
Daunorubicin—Oedema—Vincristine—colon cancer	8.4e-05	0.00159	CcSEcCtD
Daunorubicin—Stomatitis—Capecitabine—colon cancer	8.37e-05	0.00159	CcSEcCtD
Daunorubicin—Infection—Vincristine—colon cancer	8.35e-05	0.00158	CcSEcCtD
Daunorubicin—Conjunctivitis—Capecitabine—colon cancer	8.35e-05	0.00158	CcSEcCtD
Daunorubicin—Convulsion—Fluorouracil—colon cancer	8.32e-05	0.00158	CcSEcCtD
Daunorubicin—Confusional state—Irinotecan—colon cancer	8.25e-05	0.00157	CcSEcCtD
Daunorubicin—Thrombocytopenia—Vincristine—colon cancer	8.23e-05	0.00156	CcSEcCtD
Daunorubicin—ABCG2—lymph node—colon cancer	8.21e-05	0.00326	CbGeAlD
Daunorubicin—Oedema—Irinotecan—colon cancer	8.18e-05	0.00155	CcSEcCtD
Daunorubicin—Anaphylactic shock—Irinotecan—colon cancer	8.18e-05	0.00155	CcSEcCtD
Daunorubicin—Chest pain—Fluorouracil—colon cancer	8.17e-05	0.00155	CcSEcCtD
Daunorubicin—Myalgia—Fluorouracil—colon cancer	8.17e-05	0.00155	CcSEcCtD
Daunorubicin—Infection—Irinotecan—colon cancer	8.13e-05	0.00154	CcSEcCtD
Daunorubicin—Hyperhidrosis—Vincristine—colon cancer	8.12e-05	0.00154	CcSEcCtD
Daunorubicin—Discomfort—Fluorouracil—colon cancer	8.08e-05	0.00153	CcSEcCtD
Daunorubicin—Shock—Irinotecan—colon cancer	8.05e-05	0.00153	CcSEcCtD
Daunorubicin—Thrombocytopenia—Irinotecan—colon cancer	8.01e-05	0.00152	CcSEcCtD
Daunorubicin—Anorexia—Vincristine—colon cancer	8.01e-05	0.00152	CcSEcCtD
Daunorubicin—Hyperhidrosis—Irinotecan—colon cancer	7.91e-05	0.0015	CcSEcCtD
Daunorubicin—Confusional state—Fluorouracil—colon cancer	7.9e-05	0.0015	CcSEcCtD
Daunorubicin—Mood swings—Methotrexate—colon cancer	7.86e-05	0.00149	CcSEcCtD
Daunorubicin—Oedema—Fluorouracil—colon cancer	7.84e-05	0.00149	CcSEcCtD
Daunorubicin—Anaphylactic shock—Fluorouracil—colon cancer	7.84e-05	0.00149	CcSEcCtD
Daunorubicin—Anorexia—Irinotecan—colon cancer	7.8e-05	0.00148	CcSEcCtD
Daunorubicin—Ataxia—Methotrexate—colon cancer	7.8e-05	0.00148	CcSEcCtD
Daunorubicin—CYP1A1—lymph node—colon cancer	7.79e-05	0.0031	CbGeAlD
Daunorubicin—Infection—Fluorouracil—colon cancer	7.78e-05	0.00148	CcSEcCtD
Daunorubicin—Rhinitis—Capecitabine—colon cancer	7.73e-05	0.00147	CcSEcCtD
Daunorubicin—Thrombocytopenia—Fluorouracil—colon cancer	7.67e-05	0.00146	CcSEcCtD
Daunorubicin—Musculoskeletal discomfort—Vincristine—colon cancer	7.65e-05	0.00145	CcSEcCtD
Daunorubicin—Tachycardia—Fluorouracil—colon cancer	7.65e-05	0.00145	CcSEcCtD
Daunorubicin—Insomnia—Vincristine—colon cancer	7.6e-05	0.00144	CcSEcCtD
Daunorubicin—Anorexia—Fluorouracil—colon cancer	7.47e-05	0.00142	CcSEcCtD
Daunorubicin—CYP3A4—liver—colon cancer	7.46e-05	0.00297	CbGeAlD
Daunorubicin—Visual impairment—Capecitabine—colon cancer	7.43e-05	0.00141	CcSEcCtD
Daunorubicin—Insomnia—Irinotecan—colon cancer	7.4e-05	0.0014	CcSEcCtD
Daunorubicin—Decreased appetite—Vincristine—colon cancer	7.3e-05	0.00139	CcSEcCtD
Daunorubicin—Dyspnoea—Irinotecan—colon cancer	7.29e-05	0.00138	CcSEcCtD
Daunorubicin—Somnolence—Irinotecan—colon cancer	7.27e-05	0.00138	CcSEcCtD
Daunorubicin—Fatigue—Vincristine—colon cancer	7.24e-05	0.00137	CcSEcCtD
Daunorubicin—Tinnitus—Capecitabine—colon cancer	7.19e-05	0.00136	CcSEcCtD
Daunorubicin—Constipation—Vincristine—colon cancer	7.18e-05	0.00136	CcSEcCtD
Daunorubicin—Pain—Vincristine—colon cancer	7.18e-05	0.00136	CcSEcCtD
Daunorubicin—ABCB1—lymphoid tissue—colon cancer	7.18e-05	0.00285	CbGeAlD
Daunorubicin—Flushing—Capecitabine—colon cancer	7.15e-05	0.00136	CcSEcCtD
Daunorubicin—Cardiac disorder—Capecitabine—colon cancer	7.15e-05	0.00136	CcSEcCtD
Daunorubicin—Musculoskeletal discomfort—Fluorouracil—colon cancer	7.14e-05	0.00135	CcSEcCtD
Daunorubicin—Decreased appetite—Irinotecan—colon cancer	7.11e-05	0.00135	CcSEcCtD
Daunorubicin—ABCB1—digestive system—colon cancer	7.09e-05	0.00282	CbGeAlD
Daunorubicin—Insomnia—Fluorouracil—colon cancer	7.09e-05	0.00134	CcSEcCtD
Daunorubicin—Fatigue—Irinotecan—colon cancer	7.05e-05	0.00134	CcSEcCtD
Daunorubicin—Pain—Irinotecan—colon cancer	7e-05	0.00133	CcSEcCtD
Daunorubicin—Constipation—Irinotecan—colon cancer	7e-05	0.00133	CcSEcCtD
Daunorubicin—Dyspnoea—Fluorouracil—colon cancer	6.99e-05	0.00133	CcSEcCtD
Daunorubicin—Somnolence—Fluorouracil—colon cancer	6.97e-05	0.00132	CcSEcCtD
Daunorubicin—Chills—Capecitabine—colon cancer	6.92e-05	0.00131	CcSEcCtD
Daunorubicin—Arrhythmia—Capecitabine—colon cancer	6.88e-05	0.00131	CcSEcCtD
Daunorubicin—Gastrointestinal pain—Vincristine—colon cancer	6.87e-05	0.0013	CcSEcCtD
Daunorubicin—Decreased appetite—Fluorouracil—colon cancer	6.81e-05	0.00129	CcSEcCtD
Daunorubicin—Alopecia—Capecitabine—colon cancer	6.81e-05	0.00129	CcSEcCtD
Daunorubicin—Pancytopenia—Methotrexate—colon cancer	6.81e-05	0.00129	CcSEcCtD
Daunorubicin—Feeling abnormal—Irinotecan—colon cancer	6.74e-05	0.00128	CcSEcCtD
Daunorubicin—Erythema—Capecitabine—colon cancer	6.71e-05	0.00127	CcSEcCtD
Daunorubicin—Dysuria—Methotrexate—colon cancer	6.7e-05	0.00127	CcSEcCtD
Daunorubicin—Neutropenia—Methotrexate—colon cancer	6.7e-05	0.00127	CcSEcCtD
Daunorubicin—Pain—Fluorouracil—colon cancer	6.7e-05	0.00127	CcSEcCtD
Daunorubicin—Gastrointestinal pain—Irinotecan—colon cancer	6.69e-05	0.00127	CcSEcCtD
Daunorubicin—Abdominal pain—Vincristine—colon cancer	6.64e-05	0.00126	CcSEcCtD
Daunorubicin—Body temperature increased—Vincristine—colon cancer	6.64e-05	0.00126	CcSEcCtD
Daunorubicin—Dysgeusia—Capecitabine—colon cancer	6.57e-05	0.00125	CcSEcCtD
Daunorubicin—ABCB1—bone marrow—colon cancer	6.53e-05	0.0026	CbGeAlD
Daunorubicin—Back pain—Capecitabine—colon cancer	6.49e-05	0.00123	CcSEcCtD
Daunorubicin—Body temperature increased—Irinotecan—colon cancer	6.47e-05	0.00123	CcSEcCtD
Daunorubicin—Abdominal pain—Irinotecan—colon cancer	6.47e-05	0.00123	CcSEcCtD
Daunorubicin—Feeling abnormal—Fluorouracil—colon cancer	6.46e-05	0.00123	CcSEcCtD
Daunorubicin—Depression—Methotrexate—colon cancer	6.37e-05	0.00121	CcSEcCtD
Daunorubicin—Tremor—Capecitabine—colon cancer	6.29e-05	0.00119	CcSEcCtD
Daunorubicin—Renal failure—Methotrexate—colon cancer	6.28e-05	0.00119	CcSEcCtD
Daunorubicin—ABCB1—vagina—colon cancer	6.26e-05	0.00249	CbGeAlD
Daunorubicin—Stomatitis—Methotrexate—colon cancer	6.23e-05	0.00118	CcSEcCtD
Daunorubicin—Ill-defined disorder—Capecitabine—colon cancer	6.22e-05	0.00118	CcSEcCtD
Daunorubicin—Urticaria—Fluorouracil—colon cancer	6.22e-05	0.00118	CcSEcCtD
Daunorubicin—Conjunctivitis—Methotrexate—colon cancer	6.21e-05	0.00118	CcSEcCtD
Daunorubicin—Anaemia—Capecitabine—colon cancer	6.2e-05	0.00118	CcSEcCtD
Daunorubicin—Body temperature increased—Fluorouracil—colon cancer	6.19e-05	0.00118	CcSEcCtD
Daunorubicin—Hypersensitivity—Vincristine—colon cancer	6.19e-05	0.00117	CcSEcCtD
Daunorubicin—Malaise—Capecitabine—colon cancer	6.05e-05	0.00115	CcSEcCtD
Daunorubicin—Hypersensitivity—Irinotecan—colon cancer	6.03e-05	0.00114	CcSEcCtD
Daunorubicin—Asthenia—Vincristine—colon cancer	6.03e-05	0.00114	CcSEcCtD
Daunorubicin—TOP2A—Vinblastine—Vincristine—colon cancer	6.02e-05	0.0358	CbGdCrCtD
Daunorubicin—Syncope—Capecitabine—colon cancer	6.02e-05	0.00114	CcSEcCtD
Daunorubicin—Leukopenia—Capecitabine—colon cancer	6.01e-05	0.00114	CcSEcCtD
Daunorubicin—Palpitations—Capecitabine—colon cancer	5.93e-05	0.00113	CcSEcCtD
Daunorubicin—Loss of consciousness—Capecitabine—colon cancer	5.9e-05	0.00112	CcSEcCtD
Daunorubicin—Asthenia—Irinotecan—colon cancer	5.87e-05	0.00111	CcSEcCtD
Daunorubicin—Cough—Capecitabine—colon cancer	5.85e-05	0.00111	CcSEcCtD
Daunorubicin—Hypertension—Capecitabine—colon cancer	5.79e-05	0.0011	CcSEcCtD
Daunorubicin—Hypersensitivity—Fluorouracil—colon cancer	5.77e-05	0.0011	CcSEcCtD
Daunorubicin—Diarrhoea—Vincristine—colon cancer	5.75e-05	0.00109	CcSEcCtD
Daunorubicin—Arthralgia—Capecitabine—colon cancer	5.71e-05	0.00108	CcSEcCtD
Daunorubicin—Chest pain—Capecitabine—colon cancer	5.71e-05	0.00108	CcSEcCtD
Daunorubicin—Myalgia—Capecitabine—colon cancer	5.71e-05	0.00108	CcSEcCtD
Daunorubicin—Anxiety—Capecitabine—colon cancer	5.69e-05	0.00108	CcSEcCtD
Daunorubicin—Discomfort—Capecitabine—colon cancer	5.64e-05	0.00107	CcSEcCtD
Daunorubicin—Diarrhoea—Irinotecan—colon cancer	5.6e-05	0.00106	CcSEcCtD
Daunorubicin—Dry mouth—Capecitabine—colon cancer	5.59e-05	0.00106	CcSEcCtD
Daunorubicin—Dizziness—Vincristine—colon cancer	5.56e-05	0.00105	CcSEcCtD
Daunorubicin—Pruritus—Fluorouracil—colon cancer	5.54e-05	0.00105	CcSEcCtD
Daunorubicin—Visual impairment—Methotrexate—colon cancer	5.53e-05	0.00105	CcSEcCtD
Daunorubicin—Confusional state—Capecitabine—colon cancer	5.52e-05	0.00105	CcSEcCtD
Daunorubicin—Oedema—Capecitabine—colon cancer	5.48e-05	0.00104	CcSEcCtD
Daunorubicin—Infection—Capecitabine—colon cancer	5.44e-05	0.00103	CcSEcCtD
Daunorubicin—Dizziness—Irinotecan—colon cancer	5.41e-05	0.00103	CcSEcCtD
Daunorubicin—Shock—Capecitabine—colon cancer	5.39e-05	0.00102	CcSEcCtD
Daunorubicin—Diarrhoea—Fluorouracil—colon cancer	5.36e-05	0.00102	CcSEcCtD
Daunorubicin—Thrombocytopenia—Capecitabine—colon cancer	5.36e-05	0.00102	CcSEcCtD
Daunorubicin—Tinnitus—Methotrexate—colon cancer	5.35e-05	0.00102	CcSEcCtD
Daunorubicin—Tachycardia—Capecitabine—colon cancer	5.34e-05	0.00101	CcSEcCtD
Daunorubicin—Vomiting—Vincristine—colon cancer	5.34e-05	0.00101	CcSEcCtD
Daunorubicin—Cardiac disorder—Methotrexate—colon cancer	5.32e-05	0.00101	CcSEcCtD
Daunorubicin—Rash—Vincristine—colon cancer	5.3e-05	0.00101	CcSEcCtD
Daunorubicin—Hyperhidrosis—Capecitabine—colon cancer	5.29e-05	0.001	CcSEcCtD
Daunorubicin—Dermatitis—Vincristine—colon cancer	5.29e-05	0.001	CcSEcCtD
Daunorubicin—ABCB1—liver—colon cancer	5.28e-05	0.0021	CbGeAlD
Daunorubicin—Headache—Vincristine—colon cancer	5.26e-05	0.000999	CcSEcCtD
Daunorubicin—Anorexia—Capecitabine—colon cancer	5.22e-05	0.00099	CcSEcCtD
Daunorubicin—Vomiting—Irinotecan—colon cancer	5.2e-05	0.000987	CcSEcCtD
Daunorubicin—Dizziness—Fluorouracil—colon cancer	5.18e-05	0.000983	CcSEcCtD
Daunorubicin—Rash—Irinotecan—colon cancer	5.16e-05	0.000979	CcSEcCtD
Daunorubicin—Dermatitis—Irinotecan—colon cancer	5.15e-05	0.000978	CcSEcCtD
Daunorubicin—Chills—Methotrexate—colon cancer	5.15e-05	0.000977	CcSEcCtD
Daunorubicin—Headache—Irinotecan—colon cancer	5.13e-05	0.000973	CcSEcCtD
Daunorubicin—Alopecia—Methotrexate—colon cancer	5.07e-05	0.000962	CcSEcCtD
Daunorubicin—Erythema—Methotrexate—colon cancer	4.99e-05	0.000948	CcSEcCtD
Daunorubicin—Nausea—Vincristine—colon cancer	4.99e-05	0.000947	CcSEcCtD
Daunorubicin—Musculoskeletal discomfort—Capecitabine—colon cancer	4.99e-05	0.000947	CcSEcCtD
Daunorubicin—Vomiting—Fluorouracil—colon cancer	4.98e-05	0.000945	CcSEcCtD
Daunorubicin—Insomnia—Capecitabine—colon cancer	4.95e-05	0.00094	CcSEcCtD
Daunorubicin—Rash—Fluorouracil—colon cancer	4.94e-05	0.000937	CcSEcCtD
Daunorubicin—Dermatitis—Fluorouracil—colon cancer	4.94e-05	0.000937	CcSEcCtD
Daunorubicin—Headache—Fluorouracil—colon cancer	4.91e-05	0.000931	CcSEcCtD
Daunorubicin—Dysgeusia—Methotrexate—colon cancer	4.89e-05	0.000928	CcSEcCtD
Daunorubicin—Dyspnoea—Capecitabine—colon cancer	4.88e-05	0.000926	CcSEcCtD
Daunorubicin—Nausea—Irinotecan—colon cancer	4.86e-05	0.000922	CcSEcCtD
Daunorubicin—Back pain—Methotrexate—colon cancer	4.83e-05	0.000917	CcSEcCtD
Daunorubicin—Decreased appetite—Capecitabine—colon cancer	4.76e-05	0.000903	CcSEcCtD
Daunorubicin—Fatigue—Capecitabine—colon cancer	4.72e-05	0.000896	CcSEcCtD
Daunorubicin—Pain—Capecitabine—colon cancer	4.68e-05	0.000889	CcSEcCtD
Daunorubicin—Constipation—Capecitabine—colon cancer	4.68e-05	0.000889	CcSEcCtD
Daunorubicin—Nausea—Fluorouracil—colon cancer	4.65e-05	0.000883	CcSEcCtD
Daunorubicin—Ill-defined disorder—Methotrexate—colon cancer	4.63e-05	0.000879	CcSEcCtD
Daunorubicin—Anaemia—Methotrexate—colon cancer	4.62e-05	0.000876	CcSEcCtD
Daunorubicin—Feeling abnormal—Capecitabine—colon cancer	4.51e-05	0.000856	CcSEcCtD
Daunorubicin—Malaise—Methotrexate—colon cancer	4.5e-05	0.000855	CcSEcCtD
Daunorubicin—Gastrointestinal pain—Capecitabine—colon cancer	4.48e-05	0.00085	CcSEcCtD
Daunorubicin—Leukopenia—Methotrexate—colon cancer	4.47e-05	0.000848	CcSEcCtD
Daunorubicin—Cough—Methotrexate—colon cancer	4.36e-05	0.000827	CcSEcCtD
Daunorubicin—Urticaria—Capecitabine—colon cancer	4.35e-05	0.000825	CcSEcCtD
Daunorubicin—Body temperature increased—Capecitabine—colon cancer	4.33e-05	0.000821	CcSEcCtD
Daunorubicin—Abdominal pain—Capecitabine—colon cancer	4.33e-05	0.000821	CcSEcCtD
Daunorubicin—Convulsion—Methotrexate—colon cancer	4.33e-05	0.000821	CcSEcCtD
Daunorubicin—Myalgia—Methotrexate—colon cancer	4.25e-05	0.000807	CcSEcCtD
Daunorubicin—Chest pain—Methotrexate—colon cancer	4.25e-05	0.000807	CcSEcCtD
Daunorubicin—Arthralgia—Methotrexate—colon cancer	4.25e-05	0.000807	CcSEcCtD
Daunorubicin—Discomfort—Methotrexate—colon cancer	4.2e-05	0.000797	CcSEcCtD
Daunorubicin—Confusional state—Methotrexate—colon cancer	4.11e-05	0.00078	CcSEcCtD
Daunorubicin—Anaphylactic shock—Methotrexate—colon cancer	4.08e-05	0.000773	CcSEcCtD
Daunorubicin—Infection—Methotrexate—colon cancer	4.05e-05	0.000768	CcSEcCtD
Daunorubicin—ABCB1—lymph node—colon cancer	4.05e-05	0.00161	CbGeAlD
Daunorubicin—Hypersensitivity—Capecitabine—colon cancer	4.03e-05	0.000766	CcSEcCtD
Daunorubicin—Thrombocytopenia—Methotrexate—colon cancer	3.99e-05	0.000757	CcSEcCtD
Daunorubicin—Hyperhidrosis—Methotrexate—colon cancer	3.94e-05	0.000748	CcSEcCtD
Daunorubicin—Asthenia—Capecitabine—colon cancer	3.93e-05	0.000745	CcSEcCtD
Daunorubicin—Anorexia—Methotrexate—colon cancer	3.89e-05	0.000737	CcSEcCtD
Daunorubicin—Pruritus—Capecitabine—colon cancer	3.87e-05	0.000735	CcSEcCtD
Daunorubicin—Diarrhoea—Capecitabine—colon cancer	3.75e-05	0.000711	CcSEcCtD
Daunorubicin—Musculoskeletal discomfort—Methotrexate—colon cancer	3.71e-05	0.000705	CcSEcCtD
Daunorubicin—Insomnia—Methotrexate—colon cancer	3.69e-05	0.0007	CcSEcCtD
Daunorubicin—Dyspnoea—Methotrexate—colon cancer	3.63e-05	0.00069	CcSEcCtD
Daunorubicin—Somnolence—Methotrexate—colon cancer	3.62e-05	0.000688	CcSEcCtD
Daunorubicin—Dizziness—Capecitabine—colon cancer	3.62e-05	0.000687	CcSEcCtD
Daunorubicin—Decreased appetite—Methotrexate—colon cancer	3.54e-05	0.000672	CcSEcCtD
Daunorubicin—Fatigue—Methotrexate—colon cancer	3.51e-05	0.000667	CcSEcCtD
Daunorubicin—Pain—Methotrexate—colon cancer	3.49e-05	0.000661	CcSEcCtD
Daunorubicin—Vomiting—Capecitabine—colon cancer	3.48e-05	0.000661	CcSEcCtD
Daunorubicin—Rash—Capecitabine—colon cancer	3.45e-05	0.000655	CcSEcCtD
Daunorubicin—Dermatitis—Capecitabine—colon cancer	3.45e-05	0.000655	CcSEcCtD
Daunorubicin—Headache—Capecitabine—colon cancer	3.43e-05	0.000651	CcSEcCtD
Daunorubicin—Feeling abnormal—Methotrexate—colon cancer	3.36e-05	0.000637	CcSEcCtD
Daunorubicin—Gastrointestinal pain—Methotrexate—colon cancer	3.33e-05	0.000632	CcSEcCtD
Daunorubicin—Nausea—Capecitabine—colon cancer	3.25e-05	0.000617	CcSEcCtD
Daunorubicin—Urticaria—Methotrexate—colon cancer	3.24e-05	0.000614	CcSEcCtD
Daunorubicin—Abdominal pain—Methotrexate—colon cancer	3.22e-05	0.000611	CcSEcCtD
Daunorubicin—Body temperature increased—Methotrexate—colon cancer	3.22e-05	0.000611	CcSEcCtD
Daunorubicin—Hypersensitivity—Methotrexate—colon cancer	3e-05	0.00057	CcSEcCtD
Daunorubicin—Asthenia—Methotrexate—colon cancer	2.92e-05	0.000555	CcSEcCtD
Daunorubicin—Pruritus—Methotrexate—colon cancer	2.88e-05	0.000547	CcSEcCtD
Daunorubicin—Diarrhoea—Methotrexate—colon cancer	2.79e-05	0.000529	CcSEcCtD
Daunorubicin—Dizziness—Methotrexate—colon cancer	2.7e-05	0.000511	CcSEcCtD
Daunorubicin—Vomiting—Methotrexate—colon cancer	2.59e-05	0.000492	CcSEcCtD
Daunorubicin—Rash—Methotrexate—colon cancer	2.57e-05	0.000488	CcSEcCtD
Daunorubicin—Dermatitis—Methotrexate—colon cancer	2.57e-05	0.000487	CcSEcCtD
Daunorubicin—Headache—Methotrexate—colon cancer	2.55e-05	0.000485	CcSEcCtD
Daunorubicin—Nausea—Methotrexate—colon cancer	2.42e-05	0.000459	CcSEcCtD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—HNF4A—colon cancer	2.42e-05	0.000967	CbGpPWpGaD
Daunorubicin—TOP2A—Mitotic G1-G1/S phases—MYC—colon cancer	2.4e-05	0.00096	CbGpPWpGaD
Daunorubicin—NR5A1—Developmental Biology—VEGFA—colon cancer	2.36e-05	0.000946	CbGpPWpGaD
Daunorubicin—CYP1A1—Aryl Hydrocarbon Receptor—MYC—colon cancer	2.34e-05	0.000937	CbGpPWpGaD
Daunorubicin—NR5A1—Developmental Biology—NRAS—colon cancer	2.33e-05	0.000934	CbGpPWpGaD
Daunorubicin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—colon cancer	2.33e-05	0.000934	CbGpPWpGaD
Daunorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—CASP3—colon cancer	2.33e-05	0.000932	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—CA7—colon cancer	2.32e-05	0.000929	CbGpPWpGaD
Daunorubicin—NR5A1—Generic Transcription Pathway—MYC—colon cancer	2.31e-05	0.000925	CbGpPWpGaD
Daunorubicin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—colon cancer	2.29e-05	0.000916	CbGpPWpGaD
Daunorubicin—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—colon cancer	2.29e-05	0.000916	CbGpPWpGaD
Daunorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—CCND1—colon cancer	2.26e-05	0.000907	CbGpPWpGaD
Daunorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—CTNNB1—colon cancer	2.24e-05	0.000898	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—CHST5—colon cancer	2.23e-05	0.000893	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—ODC1—colon cancer	2.23e-05	0.000893	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—CA7—colon cancer	2.19e-05	0.000878	CbGpPWpGaD
Daunorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1A—colon cancer	2.19e-05	0.000877	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle, Mitotic—TYMS—colon cancer	2.18e-05	0.000872	CbGpPWpGaD
Daunorubicin—NR5A1—Developmental Biology—TGFB1—colon cancer	2.17e-05	0.000868	CbGpPWpGaD
Daunorubicin—CYP1A1—Aryl Hydrocarbon Receptor—KRAS—colon cancer	2.16e-05	0.000865	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—ODC1—colon cancer	2.16e-05	0.000864	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—CHST5—colon cancer	2.16e-05	0.000864	CbGpPWpGaD
Daunorubicin—YWHAG—Apoptosis—AKT1—colon cancer	2.13e-05	0.000852	CbGpPWpGaD
Daunorubicin—NR5A1—Developmental Biology—EGFR—colon cancer	2.13e-05	0.000851	CbGpPWpGaD
Daunorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	2.08e-05	0.000835	CbGpPWpGaD
Daunorubicin—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—colon cancer	2.06e-05	0.000824	CbGpPWpGaD
Daunorubicin—CYP1A1—PPARA activates gene expression—PPARG—colon cancer	2.04e-05	0.000818	CbGpPWpGaD
Daunorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	2.03e-05	0.000812	CbGpPWpGaD
Daunorubicin—NR5A1—Developmental Biology—KRAS—colon cancer	2.01e-05	0.000804	CbGpPWpGaD
Daunorubicin—TOP2A—Circadian rythm related genes—EP300—colon cancer	2e-05	0.000801	CbGpPWpGaD
Daunorubicin—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—colon cancer	2e-05	0.0008	CbGpPWpGaD
Daunorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	1.97e-05	0.000791	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—ODC1—colon cancer	1.96e-05	0.000786	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—CHST5—colon cancer	1.96e-05	0.000786	CbGpPWpGaD
Daunorubicin—NR5A1—Gene Expression—PPARG—colon cancer	1.95e-05	0.000781	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle—TYMS—colon cancer	1.95e-05	0.00078	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—CHST5—colon cancer	1.94e-05	0.000778	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—ODC1—colon cancer	1.94e-05	0.000778	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—BUB1B—colon cancer	1.93e-05	0.000773	CbGpPWpGaD
Daunorubicin—CYP1A2—Arachidonic acid metabolism—PTGS2—colon cancer	1.92e-05	0.000771	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—AXIN2—colon cancer	1.91e-05	0.000766	CbGpPWpGaD
Daunorubicin—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—colon cancer	1.84e-05	0.000736	CbGpPWpGaD
Daunorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	1.82e-05	0.000727	CbGpPWpGaD
Daunorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	1.81e-05	0.000726	CbGpPWpGaD
Daunorubicin—YWHAG—Membrane Trafficking—AKT1—colon cancer	1.81e-05	0.000724	CbGpPWpGaD
Daunorubicin—SLC22A2—Transmission across Chemical Synapses—BRAF—colon cancer	1.8e-05	0.000722	CbGpPWpGaD
Daunorubicin—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—colon cancer	1.8e-05	0.00072	CbGpPWpGaD
Daunorubicin—ABCG2—HIF-1-alpha transcription factor network—AKT1—colon cancer	1.79e-05	0.000719	CbGpPWpGaD
Daunorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	1.78e-05	0.000711	CbGpPWpGaD
Daunorubicin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—colon cancer	1.78e-05	0.000711	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—CA7—colon cancer	1.75e-05	0.000701	CbGpPWpGaD
Daunorubicin—CYP1A2—Aryl Hydrocarbon Receptor—EP300—colon cancer	1.71e-05	0.000685	CbGpPWpGaD
Daunorubicin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—colon cancer	1.71e-05	0.000685	CbGpPWpGaD
Daunorubicin—NR5A1—Developmental Biology—HRAS—colon cancer	1.71e-05	0.000684	CbGpPWpGaD
Daunorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	1.68e-05	0.000672	CbGpPWpGaD
Daunorubicin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—colon cancer	1.66e-05	0.000666	CbGpPWpGaD
Daunorubicin—CYP1A2—Aryl Hydrocarbon Receptor—SRC—colon cancer	1.66e-05	0.000666	CbGpPWpGaD
Daunorubicin—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—colon cancer	1.62e-05	0.000649	CbGpPWpGaD
Daunorubicin—ABCB1—HIF-1-alpha transcription factor network—EP300—colon cancer	1.61e-05	0.000643	CbGpPWpGaD
Daunorubicin—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—colon cancer	1.6e-05	0.000641	CbGpPWpGaD
Daunorubicin—ABCC2—NRF2 pathway—TGFB1—colon cancer	1.57e-05	0.00063	CbGpPWpGaD
Daunorubicin—YWHAG—Cell Cycle, Mitotic—CCND1—colon cancer	1.57e-05	0.000628	CbGpPWpGaD
Daunorubicin—ABCB1—Allograft Rejection—CASP3—colon cancer	1.55e-05	0.000622	CbGpPWpGaD
Daunorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	1.54e-05	0.000617	CbGpPWpGaD
Daunorubicin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—colon cancer	1.52e-05	0.000609	CbGpPWpGaD
Daunorubicin—YWHAG—Cell Cycle, Mitotic—CDKN1A—colon cancer	1.52e-05	0.000607	CbGpPWpGaD
Daunorubicin—NR5A1—Developmental Biology—AKT1—colon cancer	1.51e-05	0.000604	CbGpPWpGaD
Daunorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	1.49e-05	0.000597	CbGpPWpGaD
Daunorubicin—CYP1A2—Aryl Hydrocarbon Receptor—MYC—colon cancer	1.49e-05	0.000597	CbGpPWpGaD
Daunorubicin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—colon cancer	1.49e-05	0.000596	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—colon cancer	1.48e-05	0.000593	CbGpPWpGaD
Daunorubicin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—colon cancer	1.46e-05	0.000584	CbGpPWpGaD
Daunorubicin—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—colon cancer	1.46e-05	0.000584	CbGpPWpGaD
Daunorubicin—YWHAG—Cell Cycle, Mitotic—EP300—colon cancer	1.44e-05	0.000578	CbGpPWpGaD
Daunorubicin—TOP2A—Circadian rythm related genes—TP53—colon cancer	1.43e-05	0.000573	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—colon cancer	1.43e-05	0.000571	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—ODC1—colon cancer	1.41e-05	0.000563	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—CHST5—colon cancer	1.41e-05	0.000563	CbGpPWpGaD
Daunorubicin—YWHAG—Cell Cycle—CCND1—colon cancer	1.4e-05	0.000561	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—CA7—colon cancer	1.4e-05	0.00056	CbGpPWpGaD
Daunorubicin—SLC22A2—Neuronal System—BRAF—colon cancer	1.38e-05	0.000553	CbGpPWpGaD
Daunorubicin—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—colon cancer	1.38e-05	0.000552	CbGpPWpGaD
Daunorubicin—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—colon cancer	1.38e-05	0.000551	CbGpPWpGaD
Daunorubicin—YWHAG—Cell Cycle—CDKN1A—colon cancer	1.36e-05	0.000543	CbGpPWpGaD
Daunorubicin—CYP1A1—PPARA activates gene expression—EP300—colon cancer	1.34e-05	0.000535	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—ODC1—colon cancer	1.33e-05	0.000532	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—CHST5—colon cancer	1.33e-05	0.000532	CbGpPWpGaD
Daunorubicin—ABCB1—Allograft Rejection—VEGFA—colon cancer	1.32e-05	0.000527	CbGpPWpGaD
Daunorubicin—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—colon cancer	1.31e-05	0.000524	CbGpPWpGaD
Daunorubicin—YWHAG—Cell Cycle—EP300—colon cancer	1.29e-05	0.000517	CbGpPWpGaD
Daunorubicin—ABCC2—Transmembrane transport of small molecules—ABCB1—colon cancer	1.27e-05	0.00051	CbGpPWpGaD
Daunorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	1.26e-05	0.000504	CbGpPWpGaD
Daunorubicin—ABCC1—Transmembrane transport of small molecules—ABCB1—colon cancer	1.26e-05	0.000504	CbGpPWpGaD
Daunorubicin—YWHAG—Cell Cycle, Mitotic—MYC—colon cancer	1.26e-05	0.000503	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism of lipids and lipoproteins—PPARG—colon cancer	1.23e-05	0.000491	CbGpPWpGaD
Daunorubicin—ABCB1—Allograft Rejection—TGFB1—colon cancer	1.21e-05	0.000484	CbGpPWpGaD
Daunorubicin—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—colon cancer	1.17e-05	0.000469	CbGpPWpGaD
Daunorubicin—YWHAG—Cell Cycle—MYC—colon cancer	1.12e-05	0.00045	CbGpPWpGaD
Daunorubicin—NR5A1—Gene Expression—MYC—colon cancer	1.11e-05	0.000445	CbGpPWpGaD
Daunorubicin—ABCG2—Transmembrane transport of small molecules—ABCB1—colon cancer	1.11e-05	0.000443	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle, Mitotic—CCND1—colon cancer	1.1e-05	0.000439	CbGpPWpGaD
Daunorubicin—SLC22A2—Transmembrane transport of small molecules—ABCB1—colon cancer	1.1e-05	0.000439	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—APC—colon cancer	1.09e-05	0.000435	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—CA7—colon cancer	1.08e-05	0.000432	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—ABCB1—colon cancer	1.06e-05	0.000426	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—ODC1—colon cancer	1.06e-05	0.000425	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—CHST5—colon cancer	1.06e-05	0.000425	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle, Mitotic—CDKN1A—colon cancer	1.06e-05	0.000425	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—TYMS—colon cancer	1.05e-05	0.000419	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle, Mitotic—EP300—colon cancer	1.01e-05	0.000404	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle—CCND1—colon cancer	9.8e-06	0.000393	CbGpPWpGaD
Daunorubicin—ABCB1—HIF-1-alpha transcription factor network—AKT1—colon cancer	9.7e-06	0.000389	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	9.64e-06	0.000386	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle—CDKN1A—colon cancer	9.48e-06	0.00038	CbGpPWpGaD
Daunorubicin—YWHAG—Cell Cycle—TP53—colon cancer	9.23e-06	0.00037	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism of lipids and lipoproteins—PPARG—colon cancer	9.21e-06	0.000369	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle—EP300—colon cancer	9.02e-06	0.000361	CbGpPWpGaD
Daunorubicin—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—colon cancer	9.01e-06	0.000361	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism of lipids and lipoproteins—PPARG—colon cancer	8.9e-06	0.000357	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle, Mitotic—MYC—colon cancer	8.79e-06	0.000352	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—CHST5—colon cancer	8.47e-06	0.000339	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—ODC1—colon cancer	8.47e-06	0.000339	CbGpPWpGaD
Daunorubicin—SLC22A2—Transmission across Chemical Synapses—HRAS—colon cancer	8.29e-06	0.000332	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—colon cancer	8.25e-06	0.00033	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism of lipids and lipoproteins—EP300—colon cancer	8.02e-06	0.000321	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle—MYC—colon cancer	7.86e-06	0.000315	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—ABCB1—colon cancer	7.85e-06	0.000314	CbGpPWpGaD
Daunorubicin—NR5A1—Gene Expression—AKT1—colon cancer	7.71e-06	0.000309	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—TYMS—colon cancer	7.7e-06	0.000309	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—colon cancer	7.66e-06	0.000307	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—colon cancer	7.46e-06	0.000299	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—PPARG—colon cancer	7.4e-06	0.000296	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—colon cancer	7.38e-06	0.000296	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	7.24e-06	0.00029	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—colon cancer	7.21e-06	0.000289	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	7.01e-06	0.000281	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	6.86e-06	0.000275	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	6.67e-06	0.000267	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—CHST5—colon cancer	6.54e-06	0.000262	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—ODC1—colon cancer	6.54e-06	0.000262	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	6.5e-06	0.00026	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle—TP53—colon cancer	6.46e-06	0.000259	CbGpPWpGaD
Daunorubicin—SLC22A2—Neuronal System—HRAS—colon cancer	6.35e-06	0.000254	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism of lipids and lipoproteins—EP300—colon cancer	6.02e-06	0.000241	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	5.98e-06	0.000239	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	5.97e-06	0.000239	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	5.93e-06	0.000238	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—ABCB1—colon cancer	5.89e-06	0.000236	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	5.85e-06	0.000234	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism of lipids and lipoproteins—EP300—colon cancer	5.83e-06	0.000233	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—PTGS2—colon cancer	5.82e-06	0.000233	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—TYMS—colon cancer	5.79e-06	0.000232	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—ABCB1—colon cancer	5.7e-06	0.000228	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—TYMS—colon cancer	5.6e-06	0.000224	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	5.53e-06	0.000221	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—FGFR3—colon cancer	5.53e-06	0.000221	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—colon cancer	5.48e-06	0.00022	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—PPARG—colon cancer	5.46e-06	0.000219	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—ABCB1—colon cancer	5.19e-06	0.000208	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—ABCB1—colon cancer	5.13e-06	0.000206	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—TYMS—colon cancer	5.09e-06	0.000204	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	5.08e-06	0.000203	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—APC—colon cancer	5.07e-06	0.000203	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—TYMS—colon cancer	5.04e-06	0.000202	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	4.91e-06	0.000197	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—EP300—colon cancer	4.84e-06	0.000194	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—BRAF—colon cancer	4.77e-06	0.000191	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	4.46e-06	0.000178	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	4.31e-06	0.000173	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	4.31e-06	0.000173	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—PTGS2—colon cancer	4.29e-06	0.000172	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	4.15e-06	0.000166	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—PPARG—colon cancer	4.1e-06	0.000164	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—PPARG—colon cancer	3.97e-06	0.000159	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—PTGS2—colon cancer	3.85e-06	0.000154	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—ABCB1—colon cancer	3.72e-06	0.000149	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—TYMS—colon cancer	3.65e-06	0.000146	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—PPARG—colon cancer	3.61e-06	0.000144	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism of lipids and lipoproteins—EP300—colon cancer	3.59e-06	0.000144	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—PIK3CA—colon cancer	3.58e-06	0.000143	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—EP300—colon cancer	3.57e-06	0.000143	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—PPARG—colon cancer	3.57e-06	0.000143	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—ABCB1—colon cancer	3.51e-06	0.000141	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—colon cancer	3.5e-06	0.00014	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—TYMS—colon cancer	3.45e-06	0.000138	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—CTNNB1—colon cancer	3.45e-06	0.000138	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—CDKN1A—colon cancer	3.37e-06	0.000135	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—PTGS2—colon cancer	3.23e-06	0.000129	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—EP300—colon cancer	3.2e-06	0.000128	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—PTGS2—colon cancer	3.12e-06	0.000125	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—SRC—colon cancer	3.11e-06	0.000125	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—NRAS—colon cancer	3e-06	0.00012	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—AKT1—colon cancer	2.93e-06	0.000117	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—PTGS2—colon cancer	2.84e-06	0.000114	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—PTGS2—colon cancer	2.81e-06	0.000112	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—MYC—colon cancer	2.79e-06	0.000112	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—TGFB1—colon cancer	2.78e-06	0.000112	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—TYMS—colon cancer	2.75e-06	0.00011	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	2.75e-06	0.00011	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—EGFR—colon cancer	2.73e-06	0.000109	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—EP300—colon cancer	2.68e-06	0.000107	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	2.65e-06	0.000106	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—PIK3CA—colon cancer	2.64e-06	0.000106	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—EP300—colon cancer	2.59e-06	0.000104	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—PPARG—colon cancer	2.59e-06	0.000104	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—KRAS—colon cancer	2.58e-06	0.000103	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—PPARG—colon cancer	2.44e-06	9.78e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—PIK3CA—colon cancer	2.37e-06	9.49e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—EP300—colon cancer	2.36e-06	9.45e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—EP300—colon cancer	2.34e-06	9.36e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—EP300—colon cancer	2.29e-06	9.16e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—ABCB1—colon cancer	2.24e-06	8.96e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—TYMS—colon cancer	2.2e-06	8.8e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—HRAS—colon cancer	2.19e-06	8.78e-05	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—AKT1—colon cancer	2.16e-06	8.64e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—PTGS2—colon cancer	2.03e-06	8.14e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—PIK3CA—colon cancer	1.98e-06	7.95e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—PPARG—colon cancer	1.95e-06	7.81e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—AKT1—colon cancer	1.94e-06	7.75e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—PTGS2—colon cancer	1.92e-06	7.69e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—PIK3CA—colon cancer	1.92e-06	7.69e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—PIK3CA—colon cancer	1.75e-06	6.99e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—PIK3CA—colon cancer	1.73e-06	6.92e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—ABCB1—colon cancer	1.73e-06	6.92e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—TYMS—colon cancer	1.7e-06	6.79e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	1.69e-06	6.78e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—EP300—colon cancer	1.69e-06	6.77e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—AKT1—colon cancer	1.62e-06	6.49e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—EP300—colon cancer	1.6e-06	6.4e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—AKT1—colon cancer	1.57e-06	6.28e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—PPARG—colon cancer	1.56e-06	6.24e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—PTGS2—colon cancer	1.53e-06	6.15e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—AKT1—colon cancer	1.43e-06	5.71e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—AKT1—colon cancer	1.41e-06	5.65e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—EP300—colon cancer	1.28e-06	5.11e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—PIK3CA—colon cancer	1.25e-06	5.01e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—PTGS2—colon cancer	1.22e-06	4.91e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—PPARG—colon cancer	1.2e-06	4.81e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—PIK3CA—colon cancer	1.18e-06	4.73e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—AKT1—colon cancer	1.02e-06	4.09e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—EP300—colon cancer	1.02e-06	4.08e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—AKT1—colon cancer	9.66e-07	3.87e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—PTGS2—colon cancer	9.45e-07	3.79e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—PIK3CA—colon cancer	9.44e-07	3.78e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—EP300—colon cancer	7.86e-07	3.15e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—AKT1—colon cancer	7.71e-07	3.09e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—PIK3CA—colon cancer	7.54e-07	3.02e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—AKT1—colon cancer	6.16e-07	2.47e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—PIK3CA—colon cancer	5.82e-07	2.33e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—AKT1—colon cancer	4.75e-07	1.9e-05	CbGpPWpGaD
